Monday, August 13, 2012

Updated information about Biomarin's BMN-111 clinical development

Biomarin has updated its website, posting more detailed information regarding the clinical development of BMN-111, a CNP analogue, the first potential pharmacological therapy for achondroplasia reaching clinical trials. 

For more details, you can visit:

You can learn more about CNP reading this previous article published in the blog:

No comments:

Post a Comment